GAPDH has been implicated in diseases such as Alzheimer’s disease (AD) and other neurodegenerative disorders [67, 68] In AD, post-translationally modified GAPDH accumulates in the brain, contributing to amyloid-β amyloidogenesis [68–70]. Here, GAPDH is linked to early-onset autosomal dominant Alzheimer disease.